NCT06444867View on ClinicalTrials.gov

A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 6, 2024

Primary Completion Date

September 8, 2025

Study Completion Date

September 8, 2025

Conditions
Joint PainGout FlaresJoint Inflammation
Interventions
DRUG

LEO 158968

SC injection

Trial Locations (3)

59400

LEO Pharma Investigational Site, Lille

5912 BL

LEO Pharma Investigational Site, Venlo

EC2Y 8EA

LEO Pharma Investigational Site, London

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT06444867 - A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968 | Biotech Hunter | Biotech Hunter